• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌相关性淋巴水肿的发生:是取决于患者、肿瘤还是治疗医生?

Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?

机构信息

King Hussein Cancer Center, Al-Jubeiha, P.O. Box 1269, Amman, 11941, Jordan,

出版信息

Surg Today. 2014 Jan;44(1):100-6. doi: 10.1007/s00595-013-0494-8. Epub 2013 Feb 2.

DOI:10.1007/s00595-013-0494-8
PMID:23377553
Abstract

INTRODUCTION

Breast cancer-related lymphedema (LE) is relatively common. The aim of this study was to identify the risk factors involved in the development of this complication.

METHODOLOGY

This was a cross-sectional study of breast cancer patients treated at our Center between 2004 and 2009. A total of 515 patients were included. Lymphedema was defined as a mid-arm or forearm circumference difference between both limbs of 2 cm or more.

RESULTS

The incidence of LE in this population was 21.4 %. Patients with a BMI of 25 or higher had a significantly higher risk of LE (p = 0.002). The presence of lymphovascular invasion (LVI) (p = 0.05) and the number of positive lymph nodes (LN) (p = 0.001) were both associated with LE. Patients who underwent axillary dissection (AD) had a significantly higher incidence of LE than patients who had a sentinel LN biopsy (25 vs. 4.5 %). Adjuvant radiotherapy was also a significant risk factor in patients who had a mastectomy (p = 0.003).

CONCLUSION

There are multiple risk factors for LE. Most of those factors can be influenced by early tumor detection. Early tumors are smaller with no LVI or axillary LN metastasis. They do not usually require AD or axillary radiotherapy, which are the strongest factors associated with the development of LE.

摘要

引言

乳腺癌相关淋巴水肿(LE)较为常见。本研究旨在确定与该并发症发展相关的风险因素。

方法

这是对 2004 年至 2009 年在我们中心治疗的乳腺癌患者进行的一项横断面研究。共纳入 515 例患者。淋巴水肿定义为双侧上肢中段或前臂周径差 2cm 或以上。

结果

该人群中 LE 的发生率为 21.4%。BMI 为 25 或更高的患者 LE 风险显著更高(p=0.002)。存在淋巴血管侵犯(LVI)(p=0.05)和阳性淋巴结(LN)数量(p=0.001)均与 LE 相关。接受腋窝清扫术(AD)的患者 LE 发生率明显高于接受前哨淋巴结活检的患者(25%比 4.5%)。乳房切除术患者接受辅助放疗也是一个显著的风险因素(p=0.003)。

结论

LE 存在多种风险因素。大多数这些因素可以通过早期肿瘤检测来影响。早期肿瘤较小,无 LVI 或腋窝 LN 转移。它们通常不需要 AD 或腋窝放疗,这是与 LE 发展最相关的两个因素。

相似文献

1
Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?乳腺癌相关性淋巴水肿的发生:是取决于患者、肿瘤还是治疗医生?
Surg Today. 2014 Jan;44(1):100-6. doi: 10.1007/s00595-013-0494-8. Epub 2013 Feb 2.
2
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.肥胖是乳腺癌患者术后发生淋巴水肿的一个风险因素。
Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.
3
The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.乳腺癌治疗后手臂淋巴水肿的发生率及发生风险因素。
Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.
4
Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.乳腺癌治疗后发生的淋巴水肿,包括前哨淋巴结活检术后的淋巴水肿。
Lymphology. 2004 Jun;37(2):73-91.
5
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
6
A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.一种用于评估乳腺癌相关淋巴水肿风险的模型:腋窝淋巴结清扫数目、辅助化疗和放疗的治疗相关因素的组合。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):498-503. doi: 10.1016/j.ijrobp.2013.02.018. Epub 2013 Mar 28.
7
The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.腋窝反向绘图相关因素对乳腺癌患者淋巴水肿的影响。
Eur J Surg Oncol. 2014 Jul;40(7):818-23. doi: 10.1016/j.ejso.2014.03.023. Epub 2014 Apr 15.
8
The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.腋窝淋巴结清扫术后亚临床淋巴水肿的检测对预防乳腺癌相关临床淋巴水肿的重要性:一项前瞻性观察研究。
Lymphat Res Biol. 2014 Dec;12(4):289-94. doi: 10.1089/lrb.2014.0035.
9
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.保乳治疗与乳房切除术后乳腺癌患者的手臂和肩部并发症
Acta Oncol. 2008;47(5):835-42. doi: 10.1080/02841860801961257.
10
Time trend of breast cancer-related lymphedema according to body mass index.根据体重指数的乳腺癌相关淋巴水肿的时间趋势。
Eur J Surg Oncol. 2024 Jun;50(6):108350. doi: 10.1016/j.ejso.2024.108350. Epub 2024 Apr 16.

引用本文的文献

1
Recent Advances in Therapeutic Modalities Against Breast Cancer-Related Lymphedema: Future Epigenetic Landscape.治疗乳腺癌相关淋巴水肿的新进展:未来的表观遗传学景观。
Lymphat Res Biol. 2023 Dec;21(6):536-548. doi: 10.1089/lrb.2022.0016. Epub 2023 Jun 2.
2
Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.乳腺癌治疗后淋巴水肿与较高体重指数相关:一项系统评价和荟萃分析。
East Afr Health Res J. 2019;3(2):178-192. doi: 10.24248/EAHRJ-D-19-00009. Epub 2019 Nov 29.
3
Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association.

本文引用的文献

1
Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.乳腺癌幸存者淋巴水肿的风险因素,爱荷华妇女健康研究。
Breast Cancer Res Treat. 2011 Dec;130(3):981-91. doi: 10.1007/s10549-011-1667-z. Epub 2011 Jul 15.
2
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.一项前瞻性乳腺癌幸存者研究中淋巴水肿的危险因素:路径研究
Arch Surg. 2010 Nov;145(11):1055-63. doi: 10.1001/archsurg.2010.231.
3
Risk factors for lymphedema after breast cancer treatment.乳腺癌治疗后淋巴水肿的风险因素。
骨髓增殖性肿瘤中的体重指数与总症状负担:发现U型关联
Cancers (Basel). 2020 Aug 6;12(8):2202. doi: 10.3390/cancers12082202.
4
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra-target-tissue irradiation.一种针对大乳房和/或高体重指数患者的新型三维适形放射治疗(3DCRT)技术:旨在减少靶区外组织照射的新型射野评估方法的评估
Br J Radiol. 2016 Sep;89(1065):20160039. doi: 10.1259/bjr.20160039. Epub 2016 Jun 29.
5
The risk of lymphedema after postoperative radiation therapy in endometrial cancer.子宫内膜癌术后放疗后发生淋巴水肿的风险。
J Gynecol Oncol. 2016 Jan;27(1):e4. doi: 10.3802/jgo.2016.27.e4. Epub 2015 Oct 8.
6
Clinical significance of breast cancer micrometastasis in the sentinel lymph node.前哨淋巴结中乳腺癌微转移的临床意义
Surg Today. 2016 Feb;46(2):155-60. doi: 10.1007/s00595-015-1168-5. Epub 2015 Apr 17.
7
Prospective surveillance of breast cancer-related lymphoedema in the first-year post-surgery: feasibility and comparison of screening measures.乳腺癌术后第一年与淋巴水肿相关的前瞻性监测:筛查措施的可行性及比较
Support Care Cancer. 2015 Jun;23(6):1549-59. doi: 10.1007/s00520-014-2504-9. Epub 2014 Nov 16.
8
Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery.细胞因子候选基因可预测乳腺癌手术后继发性淋巴水肿的发生。
Lymphat Res Biol. 2014 Mar;12(1):10-22. doi: 10.1089/lrb.2013.0024. Epub 2014 Feb 6.
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46. doi: 10.1158/1055-9965.EPI-09-1245. Epub 2010 Oct 26.
4
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.经前哨淋巴结活检或腋窝清扫后行切线野乳腺照射治疗早期乳腺癌且临床腋窝淋巴结阴性患者的 10 年治疗结果随访。
Breast Cancer Res Treat. 2011 Feb;125(3):893-902. doi: 10.1007/s10549-010-1167-6. Epub 2010 Sep 19.
5
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.NSABP B - 32试验对比前哨淋巴结清扫术与腋窝清扫术的结果显示了发病率情况。
J Surg Oncol. 2010 Aug 1;102(2):111-8. doi: 10.1002/jso.21535.
6
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.肥胖是乳腺癌患者术后发生淋巴水肿的一个风险因素。
Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.
7
A contemporary, population-based study of lymphedema risk factors in older women with breast cancer.一项针对老年乳腺癌女性淋巴水肿风险因素的当代人群研究。
Ann Surg Oncol. 2009 Apr;16(4):979-88. doi: 10.1245/s10434-009-0347-2. Epub 2009 Feb 5.
8
Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.前哨淋巴结活检或腋窝清扫术后5年乳腺癌女性患者淋巴水肿的患病率:客观测量
J Clin Oncol. 2008 Nov 10;26(32):5213-9. doi: 10.1200/JCO.2008.16.3725. Epub 2008 Oct 6.
9
Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.乳腺癌后的淋巴水肿:发病率、危险因素及对上身功能的影响。
J Clin Oncol. 2008 Jul 20;26(21):3536-42. doi: 10.1200/JCO.2007.14.4899.
10
Incidence and risk factors of breast cancer lymphoedema.乳腺癌淋巴水肿的发病率及危险因素。
J Clin Nurs. 2008 Jun;17(11):1450-9. doi: 10.1111/j.1365-2702.2007.02187.x.